VTRS - Viatris Inc


14.68
0.670   4.564%

Share volume: 11,769,672
Last Updated: 04-17-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.19%

PREVIOUS CLOSE
CHG
CHG%

$14.01
0.67
0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 09-30-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q3 2025 Q4 2025
Report Date 05-09-2024 08-08-2024 11-07-2024 02-27-2025 05-08-2025 11-06-2025 02-26-2026
Total revenue 3.663 B 3.797 B 3.751 B 3.528 B 3.254 B 3.760 B 3.704 B
Cost of revenue 2.159 B 2.351 B 2.292 B 2.313 B 2.093 B 2.388 B 2.556 B
Gross profit 1.504 B 1.445 B 1.459 B 1.215 B 1.161 B 1.372 B 1.148 B
    -3.90% 0.95% -16.74% -4.43% 18.11% -16.30%  
Operating expenses 1.217 B 1.562 B 1.202 B 1.275 B 1.170 B 1.137 B 1.354 B
Selling general and admin 1.018 B 1.358 B 1.003 B 1.047 B 948.100 M 886.600 M 1.031 B
Research and development 199.700 M 204.100 M 198.400 M 228.700 M 222.000 M 250.400 M 323.000 M
Total expenses 3.377 B 1.685 B 1.233 B 1.395 B 4.043 B 1.193 B 1.341 B
    -50.09% -26.82% 13.09% 189.89% -70.50% 12.40%  
Operating income 286.800 M -239.900 M 225.900 M -179.800 M -2.882 B 178.800 M -192.700 M
Ebit 286.800 M -246.000 M 236.100 M -406.300 M -2.982 B 111.700 M -223.400 M
Pretax income 204.600 M -391.800 M 90.500 M -526.500 M -3.097 B -7.900 M -343.000 M
    -291.50% -123.10% -681.77% 488.22% -99.74% 4,241.77%  
Income tax 90.700 M -65.400 M -4.300 M -10.000 M -55.000 M 120.300 M -2.900 M
Net income basic 113.900 M 0.000 0.000 0.000 0.000 0.000 0.000
    -100.00%            
Net income 113.900 M -326.400 M 94.800 M -516.500 M -3.042 B -128.200 M -340.100 M
    -386.57% 129.04% -644.83% -488.96% 95.79% -165.29%